Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
156,513,608
-
Share change
-
+8,387,980
-
Total reported value
-
$4,954,837,773
-
Put/Call ratio
-
48%
-
Price per share
-
$31.66
-
Number of holders
-
240
-
Value change
-
+$228,194,179
-
Number of buys
-
134
-
Number of sells
-
128
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2021
As of 31 Mar 2021,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,513,608 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, Nikko Asset Management Americas, Inc., and Sumitomo Mitsui Trust Holdings, Inc..
This page lists
240
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.